GAMCO Investors’s Fusion Pharmaceuticals Inc. Common Shares FUSN Stock Holding History

GAMCO Investors’s Portfolio FUSN Stock Details FUSN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-11,450	Closed	-$244K	–	898
2024 Q1	$244K	Buy	+11,450	New	+$137K	﹤0.01%	791

GAMCO Investors's FUSN Position: Q2 2024 in Review

GAMCO Investors sold out of Fusion Pharmaceuticals Inc. Common Shares (FUSN) in Q2 2024, closing a stake of 11,450 shares — an estimated $244K sold.

GAMCO Investors first reported a position in FUSN in Q1 2024 and held it in 1 quarter. The position peaked at $244K in Q1 2024. 0 funds tracked by Wall St. Rank hold FUSN as of Q2 2024.

GAMCO Investors reported no remaining Fusion Pharmaceuticals Inc. Common Shares position as of Q2 2024 after selling out during the quarter.
GAMCO Investors sold 11,450 Fusion Pharmaceuticals Inc. Common Shares shares in Q2 2024, an estimated $244K.
GAMCO Investors first reported a position in Fusion Pharmaceuticals Inc. Common Shares in Q1 2024 and held it in 1 quarter.
GAMCO Investors's Fusion Pharmaceuticals Inc. Common Shares position peaked at $244K in Q1 2024.
0 funds tracked by Wall St. Rank held Fusion Pharmaceuticals Inc. Common Shares as of Q2 2024.

Based on GAMCO Investors's 13F filing for Q2 2024, filed 13 Aug 2024.